MTT-Based Normalization of Glycerol Release for Accurate Quantification of Lipolysis in Primary Rat Epididymal Adipocytes

Summary

Experimental artifacts, including fluctuations in cell viability and assay interference, hinder accurate quantification of glycerol release in lipid-rich primary adipocytes. To mitigate these challenges, an MTT-based normalization strategy is used to adjust glycerol measurements for cell metabolic activity, thereby enhancing the reliability of lipolysis quantification.

Abstract

Lipolysis, a critical metabolic pathway, involves the hydrolysis of stored triglycerides into free fatty acids and glycerol. However, accurate quantification of glycerol output in lipid-rich primary adipocytes is often confounded by experimental artifacts, such as variability in cell viability and assay interference. To address these limitations, a straightforward method was established to normalize glycerol release measurements using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-based cell viability assay. This protocol leverages the difference in specific gravity between adipocytes and aqueous solutions, enabling simultaneous quantification of lipolytic output and cell viability. In drug screening experiments, pravastatin and simvastatin significantly enhanced glycerol release from abdominal adipocytes, whereas atorvastatin and lovastatin did not significantly alter glycerol output. These findings suggest that MTT-based normalization offers a robust and convenient approach for accurately quantifying lipolysis, with potential applications in drug discovery targeting obesity and metabolic syndrome. This study underscores the need to re-evaluate conventional lipolysis assays to distinguish genuine metabolic responses from nonspecific membrane leakage.

Introduction

Adipose tissue can be divided into white adipose tissue (WAT) and brown adipose tissue (BAT)¹. WAT performs the function of excess energy storage as triglycerides, while BAT has the function of heat generation to maintain body temperature, which converts chemical energy into heat energy under the stimulation of cold¹. Adipose tissue also has endocrine function². It can secrete a variety of hormones, cytokines, and metabolites (collectively referred to as adipokines), and control the energy balance of the body by regulating food-seeking behavior from the central nervous system and the metabolic act....

Protocol

This protocol leverages the difference in specific gravity between adipocytes and aqueous solutions to enable simultaneous measurement of glycerol release (as an indicator of lipolysis) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability in the same wells of a 96-well plate, thereby streamlining the experimental workflow and enhancing efficiency.

All animal procedures complied with the ARRIVE guidelines and were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 8023, revised 1978). The study protocol was approved by the Insti....

Results

After preliminary drug screening, the antihyperlipidemic drug statins were used to investigate the lipolytic effects in adipocytes by the normalized glycerol release method⁹.

The impact of statins on glycerol release from primary rat abdominal adipocytes
The effect of statins on lipolysis in primary rat abdominal adipocytes was assessed by treating the cells with 50 µM of pravastatin, simvastatin, atorvastatin, lovastatin, and 0.5% DMSO for 4 h. Ana.......

Discussion

This study provides a more accurate method to measure lipolysis in lipid-laden primary adipocytes. Pravastatin and simvastatin were found to induce glycerol release and reduce viability in rat epididymal adipocytes, whereas atorvastatin and lovastatin showed no significant effects. The administration of simvastatin resulted in a minimal rise in glycerol release from adipocytes. To address this issue, the MTT assay was employed to standardize the measurement of lipolysis. This approach revealed a significant enhancement i.......

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
0.22-µm filter	Sangon Biotech Co. Ltd.	F513165-0001	syringe filter, aquo-system, sterile
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide	Sangon Biotech Co. Ltd.	A600799-0001	1 g
96-well cell culture plates	Sangon Biotech Co. Ltd.	F603204-0001	sterile
Atorvastatin calcium salt	Cayman Chemical	10493-5	5 mg
Cell strainer	Sangon Biotech Co. Ltd.	F513450-0001	80 screen mesh
Chloral hydrate	Sangon Biotech Co. Ltd.	A500288-0250	250 g
Dimethyl sulfoxide	Sangon Biotech Co. Ltd.	A460700-0100	100 mL
Dulbecco's Modified Eagle Medium	Sangon Biotech Co. Ltd.	E600003	500 mL, high glucose, sterile
Fetal bovine serum	Sangon Biotech Co. Ltd.	E600001	100 ml, sterile
Glycerol Colorimetric Assay Kit	Cayman Chemical	10010755-96	96 wells
Lovastatin	Cayman Chemical	10010338-5	5 mg
Male adult rats	Putian University	Wistar	approximately 10-12 weeks
Penicillin-streptomycin solution	Sangon Biotech Co. Ltd.	B540732-0010	10 mL, sterile
Phosphate buffered saline	Sangon Biotech Co. Ltd.	E607009-0500	500 mL, sterile, no calcium or magnesium
Pravastatin sodium salt	Cayman Chemical	10010343-5	5 mg
Simvastatin	Cayman Chemical	10010344-5	5 mg
Trypsin solution	Sangon Biotech Co. Ltd.	E607003-0100	100 mL, without EDTA and phenol red, sterile
Type II collagenase	Sangon Biotech Co. Ltd.	A004174-0100	100 mg